Navigation Links
Onyx Pharmaceuticals Reports Second Quarter and Six-Month 2008 Financial Results
Date:8/5/2008

the recent approval in China, Nexavar now has the opportunity to help patients in a country where liver cancer claims hundreds of thousands of lives annually. Additionally, last month we were pleased to have the results of the pivotal Phase 3 liver cancer study for Nexavar published in The New England Journal of Medicine, reaching an unprecedented number of new physicians around the world."

Dr. Coles added, "Simultaneous with our sales achievements this quarter, we continue to make focused investments aimed at maximizing both the near-term and long-term value of this important oncology agent. This includes investing in expanded commercial capabilities to support the liver cancer indication, as well as, continuing to support a robust development program to identify new opportunities for the use of Nexavar and to drive our growth strategy for the brand."

Net Revenue from Unconsolidated Joint Business

For the quarter ended June 30, 2008, Onyx reported net revenue from unconsolidated joint business of $30.2 million compared to $7.5 million for the same period in 2007. The increase in net revenue from unconsolidated joint business over prior year is due to increases in Nexavar revenue recognized by Bayer and royalty revenue offset by the increase in combined commercial and research and development expenses for Nexavar. The calculation of this line item is shown in the table following the Condensed Statement of Operations.

Operating Expenses

In the second quarter of 2008, Onyx recorded research and development expenses of $8.6 million, an increase of $2.2 million over the second quarter of 2007. The increase in expenses incurred in the second quarter of 2008 was primarily due to higher costs incurred for the breast cancer program. Research and development expenses included $0.8 million of employee stock-based compensation for the second quarter of 2008 compared to $0.7 million for the second quarter of 2007.

In the second quarter
'/>"/>

SOURCE Onyx Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related biology technology :

1. Vion Pharmaceuticals Pays Interest on 7.75% Convertible Senior Notes
2. China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results
3. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
4. XTL Biopharmaceuticals Announces Financial Results for the Six Months Ended June 30, 2007
5. Cadence Pharmaceuticals Reports Second Quarter 2007 Financial Results
6. Nabi Biopharmaceuticals to Present at Upcoming Industry Conferences
7. Anadys Pharmaceuticals Appoints Steve Worland, Ph.D. as President and Chief Executive Officer
8. Poniard Pharmaceuticals Announces Participation in Upcoming Conferences
9. NovaQuest Advances Virtual Development Model With Strategic Investment in TOPIGEN Pharmaceuticals
10. Drug Royalty Corporation (DRC) Announces Acquisition Regarding PEG-INTRON(R) From Enzon Pharmaceuticals, Inc. (ENZN)
11. Sunesis Pharmaceuticals Announces Reorganization to Focus Resources and Build Value in Clinical-Stage Programs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/29/2015)... Pa. (PRWEB) May 29, 2015 ... Product Solutions with a request to design an ... excess moisture from prescription medications being produced using ... solution that includes a robotic gantry, heat-saving windows, ... and dries trays of 3D-printed pills to exact ...
(Date:5/29/2015)... May 28, 2015 Research and Markets ... Jain PharmaBiotech,s new report "Cytogenetics - Technologies, ... This report deals with cytogenetics in a ... to describe the chromosome structure and identify abnormalities ... biology, it is also referred to as molecular ...
(Date:5/29/2015)... 2015 Seoul Semiconductor (CEO: Chung-hoon ... technology, on May 28th announced that it will ... strengthening its high efficient and high reliable LED ... 2011 Seoul Semiconductor has developed efficient and reliable ... has supplied LEDs for headlamps to global auto ...
(Date:5/28/2015)... 28, 2015 Research ... the addition of Jain PharmaBiotech,s new report ... and Companies" to their offering. ... This report deals with therapeutic drug monitoring, ... patient care by monitoring drug levels in ...
Breaking Biology Technology:New industrial oven with “pill pushing” robotic gantry precisely removes excess moisture from 3D-printed pharmaceuticals 2Global Cytogenetics Market Report 2015-2024 - Technologies, Markets and Companies 2Global Cytogenetics Market Report 2015-2024 - Technologies, Markets and Companies 3Seoul Semiconductor Increases the Global Automotive LED Market Share with its High Efficient and Reliable LEDs for Automotive Lightings 2Global Therapeutic Drug Monitoring Market 2015-2024 2
... 2012  Keryx Biopharmaceuticals, Inc. (Nasdaq: KERX) today announced that ... presenting at JP Morgan,s 30th Annual Healthcare Conference, being ... presentation is scheduled to take place on Thursday, January ... A live audio webcast of Mr. Bentsur,s presentation ...
... Vermillion, Inc. (NASDAQ: VRML ... and cardiology, announced a plan to streamline its organization and ... of Directors have reviewed the company,s first complete year of ... leverage the milestones achieved in 2011.    With ...
... Inc. (NYSE Amex: INO), which is revolutionizing vaccines to ... has promoted Niranjan Y. Sardesai, Ph.D., from Senior Vice ... his expanded role, Dr. Sardesai will be responsible for ... to continuing to oversee research and development. Inovio also ...
Cached Biology Technology:Keryx Biopharmaceuticals to Present at JP Morgan's 30th Annual Healthcare Conference 2Vermillion Sharpens Focus and Streamlines Operations in 2012 2Vermillion Sharpens Focus and Streamlines Operations in 2012 3Inovio Pharmaceuticals Promotes Niranjan Sardesai to Chief Operating Officer 2Inovio Pharmaceuticals Promotes Niranjan Sardesai to Chief Operating Officer 3Inovio Pharmaceuticals Promotes Niranjan Sardesai to Chief Operating Officer 4Inovio Pharmaceuticals Promotes Niranjan Sardesai to Chief Operating Officer 5
(Date:4/27/2015)... April 27, 2015  For more than four decades, ... has been the premier worldwide event for the unmanned ... a must-attend event for any local, national, or trade ... emerging commercial markets and current applications of unmanned technologies. ... this projected $48 billion industry, and how it will ...
(Date:4/21/2015)... , April 21, 2015 ... government policies are boosting access control systems market in ... According to a recently published report by TechSci Research ... ", the access control systems market in ... billion by 2020.The access control systems market in the ...
(Date:4/17/2015)... Increasing adoption in ... to drive biometric systems market in ... According to a recently released TechSci Research ... biometric systems market in Saudi Arabia ... CAGR of over 22% through 2020. The market ...
Breaking Biology News(10 mins):UNMANNED SYSTEMS 2015: Largest International Conference and Trade Show for the Drone and Unmanned Technology Industry 2UNMANNED SYSTEMS 2015: Largest International Conference and Trade Show for the Drone and Unmanned Technology Industry 3UNMANNED SYSTEMS 2015: Largest International Conference and Trade Show for the Drone and Unmanned Technology Industry 4UNMANNED SYSTEMS 2015: Largest International Conference and Trade Show for the Drone and Unmanned Technology Industry 5Saudi Arabia Access Control Systems Market to Touch USD1.2 Billion by 2020 Says TechSci Research 2Saudi Arabia Access Control Systems Market to Touch USD1.2 Billion by 2020 Says TechSci Research 3Saudi Arabia Biometric Systems Market to Grow at 22% Through 2020, Says TechSci Research 2Saudi Arabia Biometric Systems Market to Grow at 22% Through 2020, Says TechSci Research 3
... the world,s most threatened bird species can be beneficial ... from extinction - according to counterintuitive new findings by ... in the peer-reviewed journal Animal Conservation , the ... behind the decline of the critically endangered white-shouldered ibis. ...
... DC U.S. Secretary of Energy Steven Chu announced ... the 100 awards given out this year by R&D ... commercial potential. The coveted awards are presented annually ... software developed throughout the world and introduced into the ...
... EUREKA E! 3722 4 SAVE project has resulted in a ... paramedics to a disaster area and immediately carry up to ... development of a completely new type of four-stretcher support that ... high performance materials and can be adapted to a range ...
Cached Biology News:Humans lend a hand to critically endangered waterbird 2DOE-funded research projects win 46 R&D 100 Awards for 2009 2DOE-funded research projects win 46 R&D 100 Awards for 2009 3DOE-funded research projects win 46 R&D 100 Awards for 2009 4DOE-funded research projects win 46 R&D 100 Awards for 2009 5DOE-funded research projects win 46 R&D 100 Awards for 2009 6DOE-funded research projects win 46 R&D 100 Awards for 2009 7DOE-funded research projects win 46 R&D 100 Awards for 2009 8DOE-funded research projects win 46 R&D 100 Awards for 2009 9DOE-funded research projects win 46 R&D 100 Awards for 2009 10DOE-funded research projects win 46 R&D 100 Awards for 2009 11DOE-funded research projects win 46 R&D 100 Awards for 2009 12DOE-funded research projects win 46 R&D 100 Awards for 2009 13DOE-funded research projects win 46 R&D 100 Awards for 2009 14High-tech vehicle design boosts emergency rescue capacity 2High-tech vehicle design boosts emergency rescue capacity 3
Recommend to use at 1000X dilutions for cell culture (e.g. Add 1 ul to 1 ml of culture medium.)...
Recombinant Human CCL21/6Ckine (Mucin Stalk Chimera)...
One-step, microplate or cuvet, colorimetric, detection range 0.78 ug/dL to 65 ug/dL Zn in serum, plasma, urine, saliva etc. Procedure: 10 min....
Zebrafish Ephrin-B2 Biotinylated Affinity Purified PAb...
Biology Products: